InvestorsHub Logo
Followers 87
Posts 6642
Boards Moderated 1
Alias Born 09/18/2009

Re: cowtown jay post# 41104

Sunday, 12/03/2023 6:39:17 PM

Sunday, December 03, 2023 6:39:17 PM

Post# of 42751
I can't find the specific post I need to clarify the status of the various trials, but I found something close. I believe the person I contacted was with the IMPACT group, conducting the RATinG study of aGvHD.

"IMPACT is going to do an interim assessment of the first 20 patients who get enrolled in their 18 treatment centers.

"The first stage of the trial is expected to treat 20 participants with lenzilumab before conducting an interim assessment of safety, efficacy, and feasibility."

https://ir.humanigen.com/English/news/news-details/2023/Humanigen-Announces-First-Participant-Dosed-in-RATinG-Trial-of-Lenzilumab-for-Early-Treatment-of-Acute-Graft-Versus-Host-Disease-Following-Allogeneic-Stem-Cell-Transplantation/default.aspx

So it may not take long for the data monitoring committee to collect and review data from 20 patients, from 18 sites, and making a recommendation to a second trial stage. Maybe we'll hear something about that CMML patient who progressed to needing aGvHD to be cured of his cancer."

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172695604

So I hope we will hear more from this trial.